Antidepressants and health-related quality of life (HRQoL) for patients with depression: Analysis of the medical expenditure panel survey from the United States
- PMID: 35442954
- PMCID: PMC9020683
- DOI: 10.1371/journal.pone.0265928
Antidepressants and health-related quality of life (HRQoL) for patients with depression: Analysis of the medical expenditure panel survey from the United States
Abstract
Background: Despite the empirical literature demonstrating the efficacy of antidepressant medications for treatment of depression disorder, these medications' effect on patients' overall well-being and health-related quality of life (HRQoL) remains controversial. This study investigates the effect of antidepressant medication use on patient-reported HRQoL for patients who have depression.
Methods: A comparative cohort, secondary database analysis was conducted using data from the United States' Medical Expenditures Panel Survey for patients who had depression. HRQoL was measured using the SF-12 and reported as physical and mental component summaries (PCS and MCS). A cohort of patients that used antidepressant medications were compared to a cohort of patients that did not. Univariate and multivariate difference-in-differences (D-I-D) analyses were used to assess the significance of the mean difference of change on the PCS and MCS from baseline to follow-up.
Results: On average, 17.5 million adults were diagnosed with depression disorder each year during the period 2005-2016. The majority were female (67.9%), a larger proportion of whom received antidepressant medications (60.5% vs. 51.5% of males). Although use of antidepressants was associated with some improvement on the MCS, D-I-D univariate analysis revealed no significant difference between the two cohorts in PCS (-0.35 vs. -0.34, p = 0.9595) or MCS (1.28 vs. 1.13, p = 0.6405). The multivariate D-I-D analyses ensured the robustness of these results.
Conclusion: The real-world effect of using antidepressant medications does not continue to improve patients' HRQoL over time. Future studies should not only focus on the short-term effect of pharmacotherapy, it should rather investigate the long-term impact of pharmacological and non-pharmacological interventions on these patients' HRQoL.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Impact of depression treatment on health-related quality of life among adults with cancer and depression: a population-level analysis.J Cancer Surviv. 2017 Oct;11(5):624-633. doi: 10.1007/s11764-017-0635-y. Epub 2017 Aug 10. J Cancer Surviv. 2017. PMID: 28799098
-
Depression treatment and health-related quality of life among adults with diabetes and depression.Qual Life Res. 2016 Jun;25(6):1517-25. doi: 10.1007/s11136-015-1189-y. Epub 2015 Nov 21. Qual Life Res. 2016. PMID: 26590839 Free PMC article.
-
Do depressed patients on adjunctive atypical antipsychotics demonstrate a better quality of life compared to those on antidepressants only? A comparative cross-sectional study of a nationally representative sample of the US population.Res Social Adm Pharm. 2015 Mar-Apr;11(2):228-40. doi: 10.1016/j.sapharm.2014.06.001. Epub 2014 Jun 13. Res Social Adm Pharm. 2015. PMID: 25023755
-
Treatment for Depression and Health-Related Quality of Life among Adults with Arthritis.Psychiatr Q. 2018 Mar;89(1):129-140. doi: 10.1007/s11126-017-9520-0. Psychiatr Q. 2018. PMID: 28612178 Free PMC article.
-
Improvements in Health-Related Quality of Life With Electroconvulsive Therapy: A Meta-analysis.J ECT. 2018 Jun;34(2):87-94. doi: 10.1097/YCT.0000000000000486. J ECT. 2018. PMID: 29461332 Review.
Cited by
-
Leveraging big data for causal understanding in mental health: a research framework.Front Psychiatry. 2024 Feb 19;15:1337740. doi: 10.3389/fpsyt.2024.1337740. eCollection 2024. Front Psychiatry. 2024. PMID: 38439791 Free PMC article. Review.
-
Relationship between depression, anxiety, stress, and health-related quality of life in adults with and without chronic diseases: A cross-sectional study.Medicine (Baltimore). 2024 Jan 12;103(2):e36967. doi: 10.1097/MD.0000000000036967. Medicine (Baltimore). 2024. PMID: 38215093 Free PMC article.
-
Adding online storytelling-based acceptance and commitment therapy to antidepressant treatment for primary care patients: a randomized clinical trial.Cogn Behav Ther. 2024 Jan;53(1):48-69. doi: 10.1080/16506073.2023.2265560. Epub 2024 Jan 2. Cogn Behav Ther. 2024. PMID: 37855277 Clinical Trial.
-
The effect of brief exposure to virtual nature on mental wellbeing in adolescents.Sci Rep. 2023 Oct 18;13(1):17769. doi: 10.1038/s41598-023-44717-z. Sci Rep. 2023. PMID: 37853074 Free PMC article. Clinical Trial.
-
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression.Front Psychiatry. 2023 Sep 19;14:1268832. doi: 10.3389/fpsyt.2023.1268832. eCollection 2023. Front Psychiatry. 2023. PMID: 37795512 Free PMC article.
References
-
- NIMH. Major depression: National Institute of Mental Health; 2019. [cited 2020]. Available from: https://www.nimh.nih.gov/health/statistics/major-depression.shtml.
-
- WHO. Depression: World Health Organization; [cited 2020]. Available from: https://www.who.int/health-topics/depression#tab=tab_1.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
